Ofatumumab for a rituximab-allergic child with chronic-relapsing paraneoplastic opsoclonus-myoclonus. [electronic resource]
Producer: 20120516Description: 988-91 p. digitalISSN:- 1545-5017
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antibodies, Monoclonal, Murine-Derived -- adverse effects
- Drug Hypersensitivity -- etiology
- Ganglioneuroblastoma -- complications
- Humans
- Infant
- Male
- Opsoclonus-Myoclonus Syndrome -- drug therapy
- Rituximab
- Spinal Cord Neoplasms -- complications
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.